Previous 10 | Next 10 |
Early access of novel technology that enables preparation of thousands of samples at low cost through self-normalization, enhanced multiplexing, and streamlined workflow Innovative solution positioned to drive NGS adoption in AgBio Twist Flex Prep UHT Kit and additional NGS tools to be hi...
2024-02-02 13:11:04 ET Twist Bioscience Corporation (TWST) Q1 2024 Earnings Conference Call February 2, 2024 08:00 AM ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs Emily Leproust - Chief Executive Officer & Co-Founder Adam ...
2024-02-02 07:34:45 ET More on Twist Bioscience Twist Bioscience: Continued Progress Despite Headwinds Twist Bioscience expands express genes service Seeking Alpha’s Quant Rating on Twist Bioscience Read the full article on Seeking Alpha For fu...
– Record revenue of $71.5M in 1QFY24, an increase of 32% over $54.2M in 1QFY23 – – Orders increased to $77.5M in 1QFY24, an increase of 19% over 1QFY23 – — Increased FY 2024 revenue guidance to $288M to $293M; Increased FY 2024 gross margin guidance to 4...
Atlas Lithium Corporation (ATLX) is expected to report $-0.47 for Q4 2023 Capital Product Partners L.P. (CPLP) is expected to report $0.7 for Q4 2023 WisdomTree Inc. (WT) is expected to report $0.11 for Q4 2023 Mitsubishi Corporation (MSBHF) is expected to report for Q3 2024 C3is ...
2024-02-01 11:40:33 ET More on Twist Bioscience Twist Bioscience: Continued Progress Despite Headwinds Twist Bioscience Corporation (TWST) Q4 2023 Earnings Call Transcript Twist Bioscience expands express genes service Goldman ups Twist Bioscience to buy, cit...
2024-01-24 08:48:05 ET More on Twist Bioscience Twist Bioscience: Continued Progress Despite Headwinds Twist Bioscience Corporation (TWST) Q4 2023 Earnings Call Transcript A New Look At Twist Bioscience Goldman ups Twist Bioscience to buy, cites Express Genes...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes , a new leading gene synthesis service with an order to shipping turnaroun...
2024-01-18 21:08:20 ET Summary ARK Invest's 13F portfolio value increased by 29% this quarter, reaching approximately $16.89 billion. The top three holdings in the portfolio are Coinbase Global, UiPath, and Tesla. ARK Invest made new stakes in ProShares Bitcoin Strategy ETF an...
2024-01-17 13:48:29 ET More on Twist Bioscience Twist Bioscience: Continued Progress Despite Headwinds Twist Bioscience Corporation (TWST) Q4 2023 Earnings Call Transcript A New Look At Twist Bioscience Quants and short traders both love these stocks - who wi...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...